News
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Think of them as medical detectives, helping doctors detect issues at the genomic level before they become life-threatening ...
Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Out of the 473 stocks that reached new 52-week highs and 105 that slid to fresh lows across the NYSE and Nasdaq yesterday, ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Research published in ACS Chemical Biology and BioDesign Research describes new approaches for producing tryptamine and MDMA-derived compoundsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences ...
Israel-based Check-Cap (CHEK) stock jumped about 390% to $3.67 on Monday during pre-market hours of trading, as it announced ...
Allarity has secured exclusive global rights for the development and commercialization of stenoparib, which was originally developed by Eisai Co. Ltd. and was formerly known under the names E7449 and ...
The Global X SuperDividend U.S. ETF (DIV) offers a 6.7% yield by focusing on 50 high-yielding, primarily micro-cap U.S.
Since the partnership began in 2021, more than seven million guests have been screened upon entry to Gilette Stadium by the Evolv Express units. "We're very pleased to expand and extend our ...
Postpartum depression is a leading cause of maternal mortality in Europe1-2, and is one of the most common medical conditions associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results